Have your own idea? Try our Stock Screener
Pakistani (KSE) Healthcare Sector Analysis
UpdatedOct 15, 2025
DataAggregated Company Financials
Companies15
- 7D-1.0%
- 3M8.3%
- 1Y83.0%
- YTD8.7%
In the last week, the Healthcare industry is flat overall, with GlaxoSmithKline Pakistan standing out by going down 3.6%. The past year has been better, since the industry has gained 83% in that time. As for the next few years, earnings are expected to grow by 22% per annum.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 15 Oct 2025 | PK₨595.8b | PK₨332.5b | PK₨31.5b | 22.7x | 18.9x | 1.8x |
| Fri, 12 Sep 2025 | PK₨587.4b | PK₨328.9b | PK₨32.0b | 20.5x | 18.3x | 1.8x |
| Sun, 10 Aug 2025 | PK₨568.5b | PK₨312.5b | PK₨28.6b | 21.4x | 19.9x | 1.8x |
| Tue, 08 Jul 2025 | PK₨560.7b | PK₨312.5b | PK₨28.6b | 20.3x | 19.6x | 1.8x |
| Thu, 05 Jun 2025 | PK₨502.6b | PK₨312.5b | PK₨28.6b | 17.3x | 17.6x | 1.6x |
| Sat, 03 May 2025 | PK₨484.9b | PK₨305.7b | PK₨25.4b | 18.1x | 19.1x | 1.6x |
| Mon, 31 Mar 2025 | PK₨537.4b | PK₨302.6b | PK₨25.0b | 20.4x | 21.5x | 1.8x |
| Wed, 26 Feb 2025 | PK₨526.6b | PK₨288.0b | PK₨21.1b | 23.8x | 24.9x | 1.8x |
| Fri, 24 Jan 2025 | PK₨548.4b | PK₨287.8b | PK₨20.9b | 22.6x | 26.2x | 1.9x |
| Sun, 22 Dec 2024 | PK₨505.8b | PK₨287.7b | PK₨20.8b | 22.1x | 24.3x | 1.8x |
| Tue, 19 Nov 2024 | PK₨424.6b | PK₨287.7b | PK₨20.8b | 19.6x | 20.4x | 1.5x |
| Thu, 17 Oct 2024 | PK₨321.5b | PK₨273.9b | PK₨16.7b | 18.4x | 19.2x | 1.2x |
| Sat, 14 Sep 2024 | PK₨285.9b | PK₨280.5b | PK₨13.7b | 12.9x | 20.8x | 1x |
| Mon, 12 Aug 2024 | PK₨259.7b | PK₨272.9b | PK₨9.7b | 14.6x | 26.9x | 1x |
| Wed, 10 Jul 2024 | PK₨271.4b | PK₨272.9b | PK₨9.7b | 14.3x | 28.1x | 1x |
| Fri, 07 Jun 2024 | PK₨233.7b | PK₨267.6b | PK₨9.4b | 14.1x | 24.8x | 0.9x |
| Sun, 05 May 2024 | PK₨206.1b | PK₨263.7b | PK₨10.4b | 13.3x | 19.7x | 0.8x |
| Tue, 02 Apr 2024 | PK₨187.1b | PK₨254.3b | PK₨8.6b | 13x | 21.7x | 0.7x |
| Thu, 29 Feb 2024 | PK₨189.8b | PK₨248.2b | PK₨7.9b | 13.5x | 24.1x | 0.8x |
| Sat, 27 Jan 2024 | PK₨178.5b | PK₨248.2b | PK₨7.9b | 12.9x | 22.7x | 0.7x |
| Mon, 25 Dec 2023 | PK₨181.2b | PK₨248.2b | PK₨7.9b | 13.6x | 23x | 0.7x |
| Wed, 22 Nov 2023 | PK₨177.9b | PK₨245.1b | PK₨7.8b | 14.5x | 22.8x | 0.7x |
| Fri, 20 Oct 2023 | PK₨152.4b | PK₨237.4b | PK₨8.2b | 12.5x | 18.6x | 0.6x |
| Sun, 17 Sep 2023 | PK₨136.2b | PK₨234.0b | PK₨9.9b | 10.4x | 13.7x | 0.6x |
| Tue, 15 Aug 2023 | PK₨156.2b | PK₨230.3b | PK₨10.4b | 12.5x | 15x | 0.7x |
| Thu, 13 Jul 2023 | PK₨160.4b | PK₨230.3b | PK₨10.4b | 13.1x | 15.4x | 0.7x |
| Sat, 10 Jun 2023 | PK₨150.6b | PK₨230.3b | PK₨10.4b | 11.6x | 14.5x | 0.7x |
| Mon, 08 May 2023 | PK₨155.7b | PK₨217.9b | PK₨14.9b | 8.8x | 10.4x | 0.7x |
| Wed, 05 Apr 2023 | PK₨155.7b | PK₨214.7b | PK₨16.5b | 9.1x | 9.4x | 0.7x |
| Fri, 03 Mar 2023 | PK₨155.3b | PK₨212.4b | PK₨16.7b | 8.2x | 9.3x | 0.7x |
| Sun, 29 Jan 2023 | PK₨150.9b | PK₨211.8b | PK₨16.8b | 8.3x | 9x | 0.7x |
| Tue, 27 Dec 2022 | PK₨174.9b | PK₨210.9b | PK₨16.9b | 9.2x | 10.4x | 0.8x |
| Thu, 24 Nov 2022 | PK₨207.7b | PK₨210.0b | PK₨16.6b | 11.1x | 12.5x | 1x |
| Sat, 22 Oct 2022 | PK₨216.1b | PK₨201.9b | PK₨18.9b | 11.3x | 11.4x | 1.1x |
Price to Earnings Ratio
11.4x
Current Industry PE
- Investors are relatively neutral on the Pakistani Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 18.9x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 19% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | -0.68% | |
| Healthcare | -0.99% | |
| Life Sciences | 2.97% | |
| Pharma | -1.11% | |
| Healthcare Services | -1.32% | |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 19.8x.
- Analysts expect its future annual earnings growth (22.2%) to be largely in line with prior year's earnings growth.
- Investors are most pessimistic about the Healthcare Services industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 10.9x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 22% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Pharma industry is expected to see its earnings grow by 22% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SEARL Searle | PK₨104.46 | 3.5% +PK₨2.1b | 89.7% | PE78.7x | |
| HPL Hoechst Pakistan | PK₨4.15k | 4.2% +PK₨1.6b | 87.2% | PE16.9x | |
| AGP AGP | PK₨198.10 | 2.7% +PK₨1.5b | 63.1% | PE16.5x | |
| FEROZ Ferozsons Laboratories | PK₨420.93 | 5.0% +PK₨874.6m | 45.4% | PE23.6x | |
| BFBIO BF Biosciences | PK₨162.69 | 5.6% +PK₨761.4m | n/a | PE32.1x |